Answers are grounded in this paper and cite their sources.
Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with increased risk of thromboembolic stroke.1 Stroke risk in AF varies greatly with age, sex and comorbidities. CHADS2VASc score2 is a commonly used to predict the annual risk of stroke and is calculated by adding 1 point each for the presence of congestive heart failure, hypertension, age > 65 and < 75, diabetes mellitus, history of vascular disease and female sex. 2 points are added for a prior history of stroke and age ≥ 75 years. The risk of stroke increases with increasing CHADS2VASc score and oral anticoagulants (OAC) are recommended for a CHADS2VASc score of ≥ 2.1 Women have higher stroke severity than men, partly explained by a higher prevalence of AF among women presenting with stroke.3 OAC not only decrease stroke risk but also result in lower stroke severity compared to strokes in individuals with AF not on OAC.4 In spite of evidence for effectiveness in preventing stroke, OAC are underutilized4 and lower OAC prescription for women have been reported.5,6 Prescription costs have been implicated as a potential reason for lower OAC prescribing.5 This program evaluation compared OAC prescribing for women versus men with AF in the Veterans Health Administration (VA), where prescription copays are low; many veterans have no copay.7
No takes yet. Share an insight, caveat, or question.
Manja et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: